Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 2, 2007
Diabetes Care 30:1162-1167, 2007
DOI: 10.2337/dc06-2033
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc06-2033v1
30/5/1162    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorn, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorn, L. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Clustering of Risk Factors in Parents of Patients With Type 1 Diabetes and Nephropathy

Lena M. Thorn, MD1,2, Carol Forsblom, DMSC1,2, Johan Fagerudd, MD, DMSC1,2, Kim Pettersson-Fernholm, MD, DMSC1,2, Riika Kilpikari, MSC1, Per-Henrik Groop, MD, DMSC1,2 on behalf of the FinnDiane Study Group

1 Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland
2 Department of Medicine, Division of Nephrology, Helsinki University Hospital, Helsinki, Finland

Address correspondence and reprint requests to Per-Henrik Groop, MD, DMSc, Folkhälsan Research Center, Biomedicum Helsinki, POB 63, FIN-00014, University of Helsinki, Helsinki, Finland. E-mail: per-henrik.groop{at}helsinki.fi

OBJECTIVE—To assess the impact of parental risk factors for diabetic nephropathy.

RESEARCH DESIGN AND METHODS—This cross-sectional study included 2,355 type 1 diabetic patients from the FinnDiane (Finnish Diabetic Nephropathy) study. Diabetic nephropathy was defined as macroalbuminuria (urinary albumin excretion rate >200 µg/min or >300 mg/24 h) or end-stage renal disease. Information was available from 4,676 parents. Parental scores were calculated based on the number of various traits in the parents.

RESULTS—Patients with diabetic nephropathy, compared with those without diabetic nephropathy, had a higher prevalence of maternal (41 vs. 35%, P = 0.046) and parental (62 vs. 55%, P = 0.044) hypertension, maternal stroke (7.6 vs. 5.1%, P = 0.044), and maternal (1.4 vs. 0.7%, P = 0.058) and parental (4.3 vs. 2.9%, P = 0.030) type 1 diabetes. If both, compared with none, of the parents had hypertension, the adjusted odds ratio (OR) for diabetic nephropathy in offspring was 1.56 (95% CI 1.13–2.15). The adjusted OR for diabetic nephropathy was 2.13 (1.36–3.33) for the parental hypertension–diabetes score (3–4 vs. 0 points) and 2.13 (1.37–3.33) for the parental hypertension–cardiovascular disease (CVD)–diabetes score (4–6 vs. 0 points). Fathers of patients with diabetic nephropathy, compared with those without diabetic nephropathy, had reduced overall survival (log-rank P = 0.04) and reduced cardiovascular survival (log-rank P = 0.03).

CONCLUSIONS—A cluster of parental hypertension, CVD, and diabetes is associated with diabetic nephropathy in type 1 diabetes, as is paternal mortality.

Abbreviations: CVD, cardiovascular disease • FinnDiane, Finnish Diabetic Nephropathy • UAER, urinary albumin excretion rate


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
V.-P. Makinen, C. Forsblom, L. M. Thorn, J. Waden, D. Gordin, O. Heikkila, K. Hietala, L. Kyllonen, J. Kyto, M. Rosengard-Barlund, et al.
Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
Diabetes, September 1, 2008; 57(9): 2480 - 2487.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.